WorldPharmaNews
  • Home
  • Business
  • Research
  • Jobs
  • Events
  • Regulatory

Pfizer

PfizerAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us.

www.pfizer.com

Filters
List of articles in category Pfizer
Title Published Date
Pfizer unveils ATLAS®, an interactive, user-friendly website that provides global antibiotic resistance surveillance data across 60 countries 21 April 2017
XELJANZ® (tofacitinib citrate) receives marketing authorisation in the European Union for the treatment of moderate to severe active rheumatoid arthritis 27 March 2017
The Union for International Cancer Control and Pfizer announce next phase of global grants initiative supporting metastatic breast cancer patients 09 March 2017
Ronald E. Blaylock elected to Pfizer's Board of Directors 24 February 2017
Relationship expert teams up with Pfizer to address intimacy and relationship issues for people living with chronic diseases 10 February 2017
Pfizer reports fourth-quarter and full-year 2016 results 31 January 2017
Pfizer announces expansion of ASPIRE awards program for 2017 to include $5.5M in funding for breast and hematologic cancers 14 December 2016
IBM and Pfizer to accelerate immuno-oncology research with Watson for Drug Discovery 02 December 2016
Pfizer's Prevenar 13® receives approval for use in infants and children in China 02 November 2016
Pfizer awarded grant to evaluate vaccine to protect newborns against group B Streptococcus infection 19 October 2016
Pfizer decides remaining one company best positions company to maximize future value creation 26 September 2016
Pfizer launches new "Moodivator" app to help support, encourage and motivate people with depression 14 September 2016
Pfizer appoints chief scientific officer for neuroscience research 08 September 2016
Pfizer to acquire small molecule anti-infective business from AstraZeneca 24 August 2016
Pfizer announces publication of new analysis showing long-term therapy with VYNDAQEL (tafamidis) slowed progression of rare neurodegenerative disease 12 August 2016
Pfizer aims to become industry leader in gene therapy with acquisition of Bamboo Therapeutics, Inc. 02 August 2016
Pfizer receives World Health Organization prequalification for multi-dose vial presentation of Prevenar 13® 19 July 2016
Merck and Pfizer initiate Phase III trial to evaluate Avelumab as first-line treatment for ovarian cancer 07 July 2016
Pfizer completes acquisition of Anacor 24 June 2016
Help Pfizer change the future of healthy aging 21 June 2016
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • End

Business & Industry

  • Bayer exercised option to obtain full licensing rights for larotrectinib and BAY 2731954 (LOXO-195)
  • Boehringer Ingelheim (Canada) Ltd. and IBM Canada announce first of its kind collaboration to integrate blockchain technology into clinical trials
  • Merz delivers double-digit growth in strategic business areas
  • The Union for International Cancer Control and Pfizer announce new phase of global grants initiative supporting metastatic breast cancer patients
  • Merck to expand US biopharmaceutical R&D facility to advance innovative clinical pipeline

Research & Development

  • Researchers develop reversible antiplatelet therapy to fight clotting, cancer metastasis
  • How Viagra puts a brake on a master growth regulator to treat heart disease
  • Nano drops a million times smaller than a teardrop explodes 19th century theory
  • New insight into cell receptors opens the way for tailored cancer drugs
  • New pill can deliver insulin
  • Simple drug combination creates new neurons from neighboring cells
  • Cannabinoid compounds may inhibit growth of colon cancer cells

Conferences & Events

  • eyeforpharma Barcelona Conference, Expo & Awards 2019
  • SMi presents the 2nd Annual Conference: Injectable Drug Delivery 2019
  • 21st Annual Superbugs & Superdrugs Conference
  • SMi Group announces the 10th Annual RNA Therapeutics Conference
  • Pre-Filled Syringes & Injectable Drug Devices Europe 2018
  • Social Media in the Pharmaceutical Industry Conference 2019
  • Lyophilization USA Conference 2018

Regulatory Affairs

  • FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain
  • FDA takes action against 17 companies for illegally selling products claiming to treat Alzheimer's disease
  • FDA approves first therapy for the treatment of adult patients with a rare blood clotting disorder
  • FDA approves first generic Advair Diskus
  • FDA approves first treatment for rare blood disease
  1. You are here:  
  2. Home
  3. Pfizer
  4. Pfizer and Lilly announce top-line results from second Phase 3 study of tanezumab in osteoarthritis pain

About

  • Home
  • Advertise
  • Privacy
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2006 - 2017. All Rights Reserved. WORLD PHARMA JOBS | PharmaNews.eu | eHealthNews.eu | (HEALTH IT) SPACE